Nonoperative Ablative Procedures for Recurrent Cancer

  • Gil Abramovici
  • Jack M. Monchik
  • Damian E. Dupuy
Chapter

Abstract

In 2009, there was an estimated 37,200 new cases of thyroid cancer detected in the United States. This astounding 206% increase in incidence over the course of a decade makes thyroid cancer the most common endocrine malignancy. The rise has partially been attributed to the increased use of ultrasonography for cancer detection and more rigorous surveillance with this imaging modality for disease recurrence. The majority of these small cancers found with imaging are of the papillary subtype, which accounts for 75–85% of all thyroid malignancies, and have a reported 10-year survival rate of 90–98%. Papillary and follicular carcinomas are both well-differentiated thyroid carcinoma (WDTC). These tumors have an excellent prognosis with surgery as the primary mode of therapy.

Keywords

Thyroid Cancer Radiofrequency Ablation Parathyroid Adenoma Percutaneous Ethanol Injection Internal Cool 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    American Cancer Society: Cancer Facts and Figures 2009 (2009) American Cancer Society, Atlanta. 2009. http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_are_the_key_statistics_for_thyroid_cancer_43.asp?sitearea=. Last accessed 2 May 2010
  2. 2.
    Landis SH, Murray T, Bolden S, Wingo PA (1999) Cancer statistics, 1999. CA Cancer J Clin 49:8–31PubMedCrossRefGoogle Scholar
  3. 3.
    Hundahl SA, Fleming ID, Fremgen AM et al (1998) A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995 [see comments]. Cancer 83:2638–2648PubMedCrossRefGoogle Scholar
  4. 4.
    Davies L, Welch HG (2006) Increasing incidence of thyroid ­cancer in the United States, 1973–2002. JAMA 295:2164–2167PubMedCrossRefGoogle Scholar
  5. 5.
    Hodgson NC, Button J, Solorzano CC (2004) Thyroid cancer: is the incidence still increasing? Ann Surg Oncol 11:1093–1097PubMedCrossRefGoogle Scholar
  6. 6.
    Kumar V, Abbas AK, Fausto N (2005) Robbins and cotran pathologic basis of disease, 7th edn. WB Saunders, St. Louis, pp 1177–1180Google Scholar
  7. 7.
    Noguchi S, Murakami N, Yamashita H, Toda M, Kawamoto H (1998) Papillary thyroid carcinoma: modified radical neck dissection improves prognosis. Arch Surg 133:276–280PubMedCrossRefGoogle Scholar
  8. 8.
    Monchik JM, Simon CJ, Caragacianu DL, Thomay AA, Tsai V, Cohen J, Mazzaglia PJ (2009) Does failure to perform prophylactic level VI node dissection leave persistent disease detectable by ultrasonography in patients with low-risk papillary carcinoma of the thyroid? Surgery 146:1182–1187PubMedCrossRefGoogle Scholar
  9. 9.
    Scheumann GF, Gimm O, Wegener G, Hundeshagen H, Dralle H (1994) Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 18:559–567PubMedCrossRefGoogle Scholar
  10. 10.
    Cobin RH, Gharib H, Bergman DA, Clark OH, Cooper DS, Daniels GH, Dickey RA, Duick DS, Garber JR, Hay ID, Kukora JS, Lando HM, Schorr AB, Zeiger MA, Thyroid Carcinoma Task Force (2001) AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology. Endocr Pract 7:202–220PubMedGoogle Scholar
  11. 11.
    Wong JB, Kaplan MM, Meyer KB, Pauker SG (1990) Ablative radioactive iodine therapy for apparently localized thyroid carcinoma. A decision analytic perspective. Endocrinol Metab Clin North Am 19:741–760PubMedGoogle Scholar
  12. 12.
    Enewold L, Zhu K, Ron E et al (2009) Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005. Cancer Epidemiol Biomarkers Prev 18:784PubMedCrossRefGoogle Scholar
  13. 13.
    Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418–428PubMedCrossRefGoogle Scholar
  14. 14.
    Dinneen SF, Valikmaki MJ, Bergstralh EJ et al (1995) Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. J Clin Endocrinol Metab 80:2041–2045PubMedCrossRefGoogle Scholar
  15. 15.
    Samaan NA, Schultz PN, Haynie TP et al (1985) Pulmonary metastasis of differentiated thyroid carcinoma: treatment results in 101 patients. J Clin Endocrinol Metab 60:376–380PubMedCrossRefGoogle Scholar
  16. 16.
    Samaan NA, Schultz PN, Hickey RC et al (1992) The results of various modalities of treatment of well differentiated thyroid carcinoma: a retrospective review of 1599 patients. J Clin Endocrinol Metab 75:714–720PubMedCrossRefGoogle Scholar
  17. 17.
    Esnaola NF, Cantor SB, Sherman SI, Lee JE, Evans DB (2001) Optimal treatment strategy in patients with papillary thyroid cancer: a decision analysis. Surgery 130:921–930PubMedCrossRefGoogle Scholar
  18. 18.
    Noguchi S, Murakami N, Kawamoto H (1994) Classification of papillary cancer of the thyroid based on prognosis. World J Surg 18:552–558PubMedCrossRefGoogle Scholar
  19. 19.
    Sugitani I, Fujimoto Y, Yamamoto N (2008) Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control. Surgery 143:35–42PubMedCrossRefGoogle Scholar
  20. 20.
    Schlumberger MJ (1998) Medical progress: papillary and follicular thyroid carcinoma. N Engl J Med 338:297–306PubMedCrossRefGoogle Scholar
  21. 21.
    Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP et al (2006) Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 91:2892–2899PubMedCrossRefGoogle Scholar
  22. 22.
    Schlumberger M, Tubiana M, De Vathaire F, Hill C, Gardet P, Travagli JP et al (1986) Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab 63:960–967PubMedCrossRefGoogle Scholar
  23. 23.
    Beierwaltes WH, Nishiyama RH, Thompson NW, Copp JE, Kubo A (1982) Survival time and ‘cure’ in papillary and follicular thyroid carcinoma with distant metastases: statistics following University of Michigan Therapy. J Nucl Med 23:561–568PubMedGoogle Scholar
  24. 24.
    Marcocci C, Pacini F, Elisei R, Schipani E, Ceccarelli C, Miccoli P et al (1989) Clinical and biologic behavior of bone metastases from differentiated thyroid carcinoma. Surgery 106:960–966PubMedGoogle Scholar
  25. 25.
    Bernier M, Leenhardt L, Hoang C et al (2001) Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab 86:1568–1573PubMedCrossRefGoogle Scholar
  26. 26.
    Casara D, Rubello D, Saladini G, Masarotto G, Favero A, Girelli ME (1993) Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med 34:1626–1631PubMedGoogle Scholar
  27. 27.
    Casara D, Rubello D, Saladini G et al (1991) Distant metastases in differentiated thyroid cancer: long-term results of radioiodine treatment and statistical analysis of prognostic factors in 214 patients. Tumori 77:432–436PubMedGoogle Scholar
  28. 28.
    Gazelle GS, Goldberg SN, Solbiati L, Livraghi T (2000) Tumor ablation with radiofrequency energy. Radiology 217:633–646PubMedGoogle Scholar
  29. 29.
    Lencioni R, Cioni D, Crocetti L, Bartolozzi C (2004) Percutaneous ablation of hepatocellular carcinoma state-of-the-art. Liver Transpl 10:S91–S97PubMedCrossRefGoogle Scholar
  30. 30.
    Rosenthal DI, Hornicek FJ, Wolfe MW et al (1998) Percutaneous radiofrequency coagulation of osteoid osteoma compared with operative treatment. J Bone Joint Surg Am 83:4195–4203Google Scholar
  31. 31.
    Dupuy DE, Hong R, Goldberg SN (2000) Radiofrequency ablation of spinal tumors: temperature distribution in the spinal canal. AJR Am J Roentgenol 175:1263–1266PubMedGoogle Scholar
  32. 32.
    Dupuy DE, Zagoria RJ, Akerley W, Mayo-Smith WW, Kavanagh PV, Safran H (2000) Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol 174:57–59PubMedGoogle Scholar
  33. 33.
    Gervais DA, McGovern FJ, Wood BJ, Goldberg SN, McDougal WS, Mueller PR (2000) Radio-frequency ablation of renal cell carcinoma: early clinical experience. Radiology 217:665–672PubMedGoogle Scholar
  34. 34.
    Dupuy DE, Mayo-Smith WW, Cronan JJ (2000) Image-guided biopsy and radiofrequency ablation of renal masses. Semin Interv Radiol 17:373–379CrossRefGoogle Scholar
  35. 35.
    Goldberg SN, Dupuy DE (2001) Image-guided radiofrequency tumor ablation: challenges and opportunities – part I. J Vasc Interv Radiol 12:1021–1032CrossRefGoogle Scholar
  36. 36.
    Dupuy DE, Goldberg SN (2001) Image-guided radiofrequency tumor ablation: challenges and opportunities – part II. J Vasc Interv Radiol 12:1135–1148PubMedCrossRefGoogle Scholar
  37. 37.
    Xin T, Sun Q, Shi X et al (2001) Relationship between thermal parameters and tumor response in hyperthermia combined with radiation therapy. Int J Clin Oncol 6:138–142CrossRefGoogle Scholar
  38. 38.
    Jain SK, Dupuy DE, Cardarelli GA et al (2003) Percutaneous radiofrequency ablation of pulmonary malignancies: combined treatment with brachytherapy. AJR Am J Roentgenol 181:711–715PubMedGoogle Scholar
  39. 39.
    Sakurai H, Hayakawa K, Mitsuhashi N et al (2002) Effect of hyperthermia combined with external radiation therapy in primary non-small cell lung cancer with direct bony invasion. Int J Hyperthermia 18:472–483PubMedCrossRefGoogle Scholar
  40. 40.
    Horkan C, Dalal K, Coderre JA et al (2005) Reduced tumor growth with combined radiofrequency ablation and radiation therapy in a rat breast tumor model. Radiology 235:81–88PubMedCrossRefGoogle Scholar
  41. 41.
    Grieco CA, Simon CJ, Mayo-Smith WW et al (2006) Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small cell lung cancer. J Vasc Interv Radiol 17:1117–1124PubMedCrossRefGoogle Scholar
  42. 42.
    Dupuy DE, Mayo-Smith WW, Abbott GF, DiPetrillo T (2002) Clinical applications of radio-frequency tumor ablation in the thorax. Radiographics 22(Spec No):S259–S269PubMedGoogle Scholar
  43. 43.
    Jackman WM, Wang XZ, Friday KJ et al (1991) Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. N Engl J Med 324:1605–1611PubMedCrossRefGoogle Scholar
  44. 44.
    Calkins H, Sousa J, el-Atassi R et al (1991) Diagnosis and cure of the Wolff-Parkinson-White syndrome or paroxysmal supraventricular tachycardias during a single electro-physiologic test. N Engl J Med 324:1612–1618PubMedCrossRefGoogle Scholar
  45. 45.
    Oturai AB, Jensen K, Eriksen J et al (1996) Neurosurgery for trigeminal neuralgia: comparison of alcohol block, neurectomy, and radiofrequency coagulation. Clin J Pain 12:311–315PubMedCrossRefGoogle Scholar
  46. 46.
    Lencioni R, Cioni D, Crocetti L et al (2005) Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234:961–967PubMedCrossRefGoogle Scholar
  47. 47.
    Solbiati L, Livraghi T, Goldberg SN et al (2001) Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 221:159–166PubMedCrossRefGoogle Scholar
  48. 48.
    Curley SA, Izzo F, Ellis LM, Vauthey JN, Vallone P (2000) Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 232:381–391PubMedCrossRefGoogle Scholar
  49. 49.
    Dupuy DE, Monchik JM, Decrea C et al (2001) Radiofrequency ablation of regional recurrence from well differentiated thyroid malignancy. Surgery 130:971–977PubMedCrossRefGoogle Scholar
  50. 50.
    Monchik JM, Donatini G, Iannuccilli J, Dupuy DE (2006) Radiofrequency ablation and percutaneous injection treatment for recurrent local and distant well-differentiated thyroid carcinoma. Ann Surg 244:296–304PubMedCrossRefGoogle Scholar
  51. 51.
    Jain SK, Dupuy DE, Jackson I (2004) Radiofrequency ablation for skeletal metastasis of papillary carcinoma of the thyroid: conjunct treatment with radioablative iodine. Endocrinologist 141:5–11CrossRefGoogle Scholar
  52. 52.
    Goldberg SN, Gazelle GS, Mueller PR (2000) Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 174:323–331PubMedGoogle Scholar
  53. 53.
    Goldberg SN (2001) Radiofrequency tumor ablation: principles and techniques. Eur J Ultrasound 13:129–147PubMedCrossRefGoogle Scholar
  54. 54.
    Siperstein AE, Gitomirski A (2000) History and technological aspects of radiofrequency thermoablation. Cancer J 6:s293–s303Google Scholar
  55. 55.
    Goldberg SN, Gazelle GS, Dawson SL et al (1995) Tissue ablation with radiofrequency: effect of probe size, gauge, duration, and temperature on lesion volume. Acad Radiol 2:399–404PubMedCrossRefGoogle Scholar
  56. 56.
    Goldberg SN, Gazelle GS, Halpern EF, Rittman WJ, Mueller PR, Rosenthal DI (1996) Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size. Acad Radiol 3:212–218PubMedCrossRefGoogle Scholar
  57. 57.
    Dodd GD 3rd, Soulen MC, Kane RA et al (2000) Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. Radiographics 20:9–27PubMedGoogle Scholar
  58. 58.
    McGahan JP, Wei-Zhong G, Brock JM et al (1996) Hepatic ablation using bipolar radiofrequency electrocautery. Acad Radiol 3:418–422PubMedCrossRefGoogle Scholar
  59. 59.
    Lorentzen T (1996) A cooled needle electrode for radiofrequency tissue ablation: thermodynamic aspects of improved performance compared with conventional needle design. Acad Radiol 3:556–563PubMedCrossRefGoogle Scholar
  60. 60.
    Solbiati L, Goldberg SN, Ierace T et al (1997) Hepatic metastases: percutaneous radiofrequency ablation with cooled-tip electrodes. Radiology 205:367–374PubMedGoogle Scholar
  61. 61.
    Goldberg SN, Stein M, Gazelle GS et al (1999) Percutaneous radiofrequency tissue ablation: optimization of pulsed-RF technique to increase coagulation necrosis. J Vasc Interv Radiol 10:907–916PubMedCrossRefGoogle Scholar
  62. 62.
    Goldberg SN, Ahmed M, Gazelle GS et al (2001) Radiofrequency thermal ablation with adjuvant saline injection: effect of electrical conductivity on tissue heating and coagulation. Radiology 219:157–165PubMedGoogle Scholar
  63. 63.
    Goldberg SN, Hahn PF, Tanabe KK et al (1998) Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol 9:101–111PubMedCrossRefGoogle Scholar
  64. 64.
    Goldberg SN, Hahn PF, Halpern E, Fogle R, Gazelle GS (1998) Radiofrequency tissue ablation: effect of pharmacologic modulation of blood flow on coagulation diameter. Radiology 209:761–769PubMedGoogle Scholar
  65. 65.
    Buscarini L, Buscarini E, Di Stasi M et al (1999) Percutaneous radiofrequency thermal ablation combined with transcatheter arterial embolization in the treatment of large hepatocellular carcinoma. Ultraschall Med 20:47–53PubMedCrossRefGoogle Scholar
  66. 66.
    Kainuma O, Asano T, Aoyama H et al (1999) Combined therapy with radiofrequency thermal ablation and intra-­arterial infusion chemotherapy for hepatic metastases from colorectal cancer. Hepatogastroenterology 46:1071–1077PubMedGoogle Scholar
  67. 67.
    Solbiati L, Ierace T, Dellanoce M, Pravettoni G, Golberg SN (1998) Percutaneous US-guided radiofrequency ablation of metastatic lymph nodes from papillary cancer of the thyroid gland: initial experience in two cases (abstr). Radiology 209(P):385Google Scholar
  68. 68.
    Fiek M, Dorwarth U, Durchlaub I et al (2004) Application of radiofrequency energy in surgical and interventional procedures: are there interactions with ICDs? Pacing Clin Electrophysiol 27:293–298PubMedCrossRefGoogle Scholar
  69. 69.
    Tong NY, Ru HJ, Ling HY, Cheung YC, Meng LW, Chung PC (2004) Extracardiac radiofrequency ablation interferes with pacemaker function but does not damage the device. Anesthesiology 100:104CrossRefGoogle Scholar
  70. 70.
    Donohoo JH, Anderson MT, Mayo-Smith WW (2007) Pacemaker reprogramming after radiofrequency ablation of a lung neoplasm. AJR Am J Roentgenol 189(4):890–892PubMedCrossRefGoogle Scholar
  71. 71.
    Goldberg SN, Clement JG, Cardella JF et al (2005) Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 16:765–778PubMedCrossRefGoogle Scholar
  72. 72.
    Rhim H, Dodd GD, Chintapalli KN et al (2004) Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographics 24:41–52PubMedCrossRefGoogle Scholar
  73. 73.
    Smith EH (1991) Complications of percutaneous abdominal fine-needle biopsy. Radiology 178:253–258PubMedGoogle Scholar
  74. 74.
    Goldberg SN, Solbiati L, Halpern EF, Gazelle GS (2000) Variables affecting proper system grounding for radiofrequency ablation in an animal model. J Vasc Interv Radiol 11:1069–1075PubMedCrossRefGoogle Scholar
  75. 75.
    Machi J (2003) Prevention of dispersive pad skin burns during RFA by a simple method. Surg Laparosc Endosc Percutan Tech 13:372–373PubMedCrossRefGoogle Scholar
  76. 76.
    Steinke K, Gananadha S, King J, Zhao J, Morris DL (2003) Dispersive pad site burns with modern radiofrequency ablation equipment. Surg Laparosc Endosc Percutan Tech 13:366–371PubMedCrossRefGoogle Scholar
  77. 77.
    Harman CR, Grant CS, Hay ID et al (1998) Indications, technique, and efficacy of alcohol injection of enlarged parathyroid glands in patients with primary hyperparathyroidism. Surgery 124:1011–1019PubMedCrossRefGoogle Scholar
  78. 78.
    Cercueil JP, Jacob D, Verges B, Holtzmann P, Lerais JM, Krause D (1998) Percutaneous ethanol injection into parathyroid adenomas: mid- and long-term results. Eur Radiol 8:1565–1569PubMedCrossRefGoogle Scholar
  79. 79.
    Chang HS, Yoon JH, Chung WY et al (1998) Sclerotherapy with OK-432 for recurrent cystic thyroid nodule. Yonsei Med J 39:367–371PubMedGoogle Scholar
  80. 80.
    Livraghi T, Paracchi A, Ferrarri C, Reschini E, Macchi RM, Bonifacino A (1994) Treatment of autonomous thyroid ­nodules with percutaneous ethanol injection: 4-year experience. Radiology 190:529–533PubMedGoogle Scholar
  81. 81.
    Rho MH, Kim DW, Kwon JS et al (2006) OK-432 sclerotherapy of plunging ranula in 21 patients: it can be a substitute for surgery. AJNR Am J Neuroradiol 27:1090–1095PubMedGoogle Scholar
  82. 82.
    Kim KH, Sung MN, Rho JL et al (2004) Sclerotherapy for congenital lesions in the head and neck. Otolaryngol Head Neck Surg 131:307–316PubMedCrossRefGoogle Scholar
  83. 83.
    Lewis BD, Hay ID, Charboneau JW et al (2002) Percutaneous ethanol injection for treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma. AJR Am J Roentgenol 178:699–704PubMedGoogle Scholar
  84. 84.
    Uflacker R, Paolini RM, Nobrega M (1986) Ablation of tumor and inflammatory tissue with absolute ethanol. Acta Radiol 27:131–138Google Scholar
  85. 85.
    Bennedbaek FN, Karstrup S, Hegedüs L (1997) Percutaneous ethanol injection therapy in the treatment of thyroid and parathyroid diseases. Eur J Endocrinol 136:240–250PubMedCrossRefGoogle Scholar
  86. 86.
    Akasu H, Shimizu K, Kitagawa W, Naito Z, Kawanami O, Tanaka S (2002) Histological study of papillary thyroid ­carcinoma treated with percutaneous ethanol injection therapy. Pathol Int 52:406–409PubMedCrossRefGoogle Scholar
  87. 87.
    Brzac HT (2009) Ultrasonography-guided therapeutic procedures in the neck region. [abstr]. Acta Med Croatica 63(Suppl 3):21–27PubMedGoogle Scholar
  88. 88.
    Lim CY, Yun JS, Lee J, Nam KH, Chung WY, Park CS (2007) Percutaneous ethanol injection therapy for locally recurrent papillary thyroid carcinoma. Thyroid 17:347–350PubMedCrossRefGoogle Scholar
  89. 89.
    Sohn YM, Hong SW, Kim EK, Kim MJ, Moon HJ, Kim SJ, Son EJ, Kwak JY (2009) Complete eradication of metastatic lymph node after percutaneous ethanol injection therapy: pathologic correlation [letter]. Thyroid 19:317–319PubMedCrossRefGoogle Scholar
  90. 90.
    Kim BM, Kim MJ, Kim EK, Park SI, Park CS, Chung WY (2008) Controlling recurrent papillary thyroid carcinoma in the neck by ultrasonography-guided percutaneous ethanol injection. Eur Radiol 18:835–842PubMedCrossRefGoogle Scholar
  91. 91.
    Mauz PS, Maassen MM, Braun B, Brosch S (2004) How safe is percutaneous ethanol injection for treatment of thyroid nodules? Report of a case of severe toxic necrosis of the larynx and adjacent skin. Acta Otolaryngol 124:1226–1230PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Gil Abramovici
    • 1
  • Jack M. Monchik
    • 1
  • Damian E. Dupuy
    • 2
  1. 1.Division of Endocrine SurgeryRhode Island Hospital and Brown Medical SchoolProvidenceUSA
  2. 2.The Warren Alpert medical School of Brown University, Rhode Island HospitalProvidenceUSA

Personalised recommendations